Cohort study of HIV-positive injection drug users

Leave a Comment / By /

BC-CfE initiates a large cohort study of HIV-positive injection drug users (IDUs) in Vancouver’s Downtown Eastside aimed at addressing barriers to HIV treatment among IDUs.

Leave a Reply

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025

Start typing and press enter to search